N
M. Kenny et al.
Feature
Synthesis
1H NMR (400 MHz, CDCl3): δ = 7.25 (t, J = 8.4 Hz, 1 H), 7.11 (ddd,
J = 8.0, 2.0, 1.2 Hz, 1 H), 6.98 (t, J = 2.0 Hz, 1 H), 6.87 (ddd, J = 8.0, 2.4,
0.8 Hz, 1 H), 4.15 (d, J = 2.4 Hz, 1 H), 3.93 (d, J = 2.4 Hz, 1 H), 3.18 (d,
J = 14.8 Hz, 1 H), 2.75 (dq, J = 14.0, 3.6 Hz, 1 H), 2.52 (dtd, J = 13.6, 3.6,
1.2 Hz, 1 H), 2.47 (d, J = 14.8 Hz, 1 H), 2.24 (td, J = 13.6, 5.6 Hz, 1 H),
2.13 (s, 3 H), 2.08–1.99 (m, 1 H), 1.90–1.73 (m, 2 H), 1.67 (tt, J = 12.8,
4.0 Hz, 1 H), 1.42 (ddd, J = 14.0, 12.4, 4.4 Hz, 1 H).
13C NMR (100 MHz, CDCl3): δ = 209.1, 204.2, 158.6, 155.0, 134.8,
130.4, 124.8, 121.7, 119.6, 91.8, 66.7, 41.9, 39.2, 34.2, 27.4, 26.7, 22.2.
HRMS (ESI): m/z [M + Na]+ calcd for C17H19ClO3Na: 329.0915; found:
329.0911.
20w
Rf = 0.29 (PE/EtOAc, 4:1).
IR (film): 2898, 2822, 1673 cm–1
1H NMR (400 MHz, CDCl3): δ = 7.51 (dd, J = 8.0, 1.6 Hz, 1 H), 7.24 (ddd,
J = 8.4, 7.6, 1.6 Hz, 1 H), 6.93 (dd, J = 8.4, 1.6 Hz, 1 H), 6.83 (td, J = 7.6,
1.6 Hz, 1 H), 5.76 (t, J = 1.2 Hz, 1 H), 5.26 (s, 1 H), 4.63 (d, J = 12.4 Hz, 1
H), 4.45 (d, J = 12.4 Hz, 1 H), 2.64–2.44 (m, 3 H), 2.27 (s, 3 H), 2.17–
2.07 (m, 1 H), 1.96–1.75 (m, 3 H), 1.73–1.60 (m, 1 H).
13C NMR (100 MHz, CDCl3): δ = 209.1, 206.9, 154.6, 141.1, 133.3,
128.4, 122.1, 119.6, 113.3, 111.9, 71.8, 69.6, 40.9, 32.8, 27.1, 27.0,
21.9.
.
HRMS (ESI): m/z [M + H]+ calcd for C17H20BrO3: 351.0590; found:
351.0580.
2-Acetyl-2-[3-(2-chlorophenoxy)prop-1-en-2-yl]cyclohexan-1-one
(20v) and 2-Acetyl-2-[2-(2-chlorophenoxy)allyl]cyclohexan-1-one
(21v)
Following method A, carbonate 3115 (53.3 mg, 0.24 mmol) was react-
ed with 2-chlorophenol (27 μL, 0.26 mmol). Flash column chromatog-
raphy (PE/EtOAc, 19:1–9:1) afforded 20v (39 mg, 53%) as a yellow oil
and an inseparable mixture of 21v and dba in a 1.2:1 ratio (23 mg,
corresponding to 12 mg of 21v, 16%) as a yellow oil.
21w
Rf = 0.40 (PE/EtOAc, 4:1); mp 46–49 °C.
IR (film): 2895, 1672, 1596 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 7.55 (dd, J = 8.0, 1.6 Hz, 1 H), 7.30–7.25
(m, 1 H), 7.06–6.99 (m, 2 H), 4.13 (d, J = 2.4 Hz, 1 H), 3.77 (d, J = 2.4 Hz,
1 H), 3.26 (d, J = 14.8 Hz, 1 H), 2.81 (dq, J = 14.0, 3.6 Hz, 1 H), 2.57 (d,
J = 14.8 Hz, 1 H), 2.52 (dtd, J = 14.0, 4.0, 1.6 Hz, 1 H), 2.31–2.19 (m, 1
H), 2.19 (s, 3 H), 2.10–1.98 (m, 1 H), 1.95–1.61 (m, 3 H), 1.51 (ddd,
J = 14.0, 12.4, 4.4 Hz, 1 H).
13C NMR (100 MHz, CDCl3): δ = 209.0, 204.6, 157.8, 151.4, 133.5,
128.7, 126.1, 123.3, 116.2, 90.8, 66.8, 41.7, 39.2, 34.2, 27.3, 26.8, 22.2.
HRMS (ESI): m/z [M + Na]+ calcd for C17H19BrO3Na: 373.0410; found:
373.0399.
20v
Rf = 0.28 (PE/EtOAc, 4:1).
IR (film): 3020, 2900, 2822, 1673, 1564 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 7.33 (dd, J = 8.0, 1.6 Hz, 1 H), 7.19 (ddd,
J = 8.4, 7.6, 1.6 Hz, 1 H), 6.96 (dd, J = 8.4, 1.6 Hz, 1 H), 6.88 (td, J = 7.6,
1.2 Hz, 1 H), 5.73 (t, J = 1.2 Hz, 1 H), 5.26 (s, 1 H), 4.64 (d, J = 12.4 Hz, 1
H), 4.47 (dd, J = 12.4, 0.8 Hz, 1 H), 2.64–2.43 (m, 3 H), 2.27 (s, 3 H),
2.16–2.07 (m, 1 H), 1.96–1.75 (m, 3 H), 1.73–1.61 (m, 1 H).
13C NMR (100 MHz, CDCl3): δ = 209.2, 206.8, 153.7, 141.3, 130.2,
127.7, 122.7, 121.6, 119.7, 113.4, 71.8, 69.7, 40.9, 32.7, 27.1, 27.0,
21.9.
HRMS (ESI): m/z [M + H]+ calcd for C17H20ClO3: 307.1095; found:
307.1088.
3-[3-(1-Isobutyryl-2-oxocyclohexyl)prop-1-en-2-yl]-3-methyl-
pentane-2,4-dione (23b)
Following method B, carbonate 1421 (47.1 mg, 0.24 mmol) was react-
ed with 2-isobutyrylcyclohexanone (40 μL, 0.24 mmol). Flash column
chromatography (PE/EtOAc, 9:1) afforded 23b (36 mg, 47%) as a yel-
low solid.
Rf = 0.25 (PE/EtOAc, 4:1); mp 40–42 °C.
21v
Rf = 0.40 (PE/EtOAc, 4:1).
IR (film): 2972, 2931, 2875, 1694, 1641 cm–1
.
IR (film): 3015, 2897, 2824, 1672, 1626, 1596, 1567 cm–1
.
1H NMR (400 MHz, CDCl3): δ = 5.02 (q, J = 1.2 Hz, 1 H), 4.87 (q, J = 1.4
Hz, 1 H), 3.01 (sept, J = 6.6 Hz, 1 H), 2.54–2.39 (m, 5 H), 2.18 (s, 3 H),
2.17 (s, 3 H), 1.79–1.60 (m, 5 H), 1.55 (s, 3 H), 1.10 (d, J = 7.1 Hz, 3 H),
0.98 (d, J = 6.2 Hz, 3 H).
13C NMR (100 MHz, CDCl3): δ = 214.8, 209.9, 207.6, 207.4, 141.4,
116.9, 71.9, 67.6, 41.5, 36.0, 35.7, 34.3, 27.2, 27.06, 27.05, 22.0, 21.0,
20.6, 18.8.
1H NMR (400 MHz, CDCl3): δ = 7.38 (dd, J = 8.0, 1.6 Hz, 1 H), 7.23 (ddd,
J = 8.0, 7.6, 1.6 Hz, 1 H), 7.12–7.06 (m, 1 H), 7.03 (dd, J = 8.0, 1.6 Hz, 1
H), 4.11 (d, J = 2.4 Hz, 1 H), 3.76 (d, J = 2.4 Hz, 1 H), 3.24 (d, J = 15.2 Hz,
1 H), 2.80 (dq, J = 14.0, 4.0 Hz, 1 H), 2.57 (d, J = 14.8 Hz, 1 H), 2.52 (dtd,
J = 14.0, 4.0, 1.6 Hz, 1 H), 2.25 (ddd, J = 13.6, 12.8, 5.6 Hz, 1 H), 2.18 (s,
3 H), 2.08–1.98 (m, 1 H), 1.95–1.75 (m, 2 H), 1.68 (qt, J = 12.8, 4.0 Hz,
1 H), 1.50 (ddd, J = 14.0, 12.4, 4.4 Hz, 1 H).
HRMS (ESI): m/z [M + H]+ calcd for C19H29O4: 321.2060; found:
321.2047.
13C NMR (100 MHz, CDCl3): δ = 209.0, 204.6, 157.8, 150.2, 130.5,
128.0, 127.0, 125.8, 123.3, 90.6, 66.7, 41.7, 39.1, 34.1, 27.3, 26.7, 22.2.
HRMS (ESI): m/z [M + Na]+ calcd for C17H19ClO3Na: 329.0915; found:
329.0905.
3-[3-(2-Acetyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)prop-1-
en-2-yl]-3-methylpentane-2,4-dione (23c)21
Carbonate 1421 (23.5 mg, 0.12 mmol), Pd2(dba)3 (5.5 mg, 0.006
mmol), DPEphos (6.5 mg, 0.012 mmol) and 2-acetyl-1-tetralone (26.7
mg, 0.12 mmol) were added to a dried tube under argon. The tube
was fitted with a septum and purged further with argon. 1,4-Dioxane
(1.5 mL) was added and the sealed tube was placed in an oil bath pre-
heated to 80 °C. The mixture was stirred at 80 °C for 2 h, then cooled
to room temperature and concentrated in vacuo. Flash column chro-
matography (PE/EtOAc, 4:1) afforded an inseparable mixture of 23c
2-Acetyl-2-[3-(2-bromophenoxy)prop-1-en-2-yl]cyclohexan-1-
one (20w) and 2-Acetyl-2-[2-(2-bromophenoxy)allyl]cyclohexan-
1-one (21w)
Following method A, carbonate 3115 (53.3 mg, 0.24 mmol) was react-
ed with 2-bromophenol (30 μL, 0.26 mmol). Flash column chroma-
tography (PE/EtOAc, 19:1–9:1) afforded 20w (41 mg, 49%) as a pale
yellow oil and an inseparable mixture of 21w and dba in a 1.8:1 ratio
(21 mg, corresponding to 9.5 mg of 21w, 11%) as a yellow solid.
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2018, 50, A–S